aminophylline has been researched along with regadenoson in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 16 (84.21) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belardinelli, L; Blackburn, B; Gordi, T; Kerensky, RA; Lieu, HD; Olmsted, AW; Shryock, JC; von Mering, GO | 1 |
| Calvin, JE; Doukky, R; Jain, S; Kiriakos, R; Morales Demori, R; Mwansa, V | 1 |
| Pandit, A; Unzek Freiman, S | 1 |
| Alqaid, A; Dick, R; Doukky, R; Margeta, B; Rangel, MO; Wassouf, M | 1 |
| Bhave, NM; Dill, K; Freed, BH; Kolanczyk, D; Lang, RM; Mor-Avi, V; Patel, AR; Yodwut, C | 1 |
| Ananthasubramaniam, K; Cabrera, R; Choudhry, Z; Dhanalakota, S; Husain, Z; Karthikeyan, AS; Palani, G; Peterson, E | 1 |
| Al-Amoodi, M; Ballany, W; Doukky, R; Mansour, K; Morales Demori, R | 1 |
| Bauml, MA; Dandekar, VK; Dickens, C; Ertel, AW; Farzaneh-Far, A; Gonzalez, RC | 1 |
| Dick, R; Doukky, R; Morales Demori, R; Rangel, MO; Voll, ST; Wassouf, M | 1 |
| Doran, JA; Gupta, R; Mackin, ML; Sajjad, W; Schneider, MD; Schwartz, RG | 1 |
| Jolly, AF; Thomas, GS | 1 |
| Ali, A; Campagnoli, T; Doukky, R; Fughhi, I | 1 |
| Bauml, MA; Chung, J; Farzaneh-Far, A; Jue, J; McGraw, S; Romano, S | 1 |
| Doukky, R; Golzar, Y; Vij, A | 1 |
| Agrawal, V; Hosey, C; Shah, C; Smith, GT | 1 |
| Bober, R; Edward, JA; Lee, JH; Morin, DP; White, CJ | 1 |
| Abidov, A; Harhash, AA; Huang, JJ; Kay, MD; Krupinski, EA; Kuo, PH; McMillan, NA; Posch, MI | 1 |
| Page, RL; Pham, VA; Quaife, RA; Raines, J; Shakowski, C | 1 |
2 review(s) available for aminophylline and regadenoson
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.
Topics: Adenosine A2 Receptor Agonists; Aminophylline; Comorbidity; Exercise Test; Humans; Kidney Failure, Chronic; Kidney Function Tests; Myocardial Perfusion Imaging; Observational Studies as Topic; Patient Safety; Prognosis; Purines; Pyrazoles; Randomized Controlled Trials as Topic; Renal Dialysis; Risk; Tomography, Emission-Computed, Single-Photon | 2018 |
9 trial(s) available for aminophylline and regadenoson
| Article | Year |
|---|---|
Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Blood Flow Velocity; Coronary Circulation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler; Vasodilator Agents | 2007 |
Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial".
Topics: Abdominal Pain; Adenosine A2 Receptor Antagonists; Aminophylline; Cardiotonic Agents; Diarrhea; Double-Blind Method; Drug Interactions; Exercise Test; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; Placebo Effect; Premedication; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2012 |
Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Chi-Square Distribution; Chicago; Diarrhea; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
Topics: Adult; Aminophylline; Blood Pressure; Chicago; Contrast Media; Coronary Circulation; Female; Heart Rate; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Recovery of Function; Reference Values; Reproducibility of Results; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left; Young Adult | 2012 |
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
Topics: Adenosine A2 Receptor Agonists; Aminophylline; Cardiotonic Agents; Double-Blind Method; Exercise Test; Female; Humans; Hyperemia; Image Enhancement; Male; Middle Aged; Myocardial Perfusion Imaging; Placebo Effect; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Cardiotonic Agents; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Gastrointestinal Tract; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Renal Insufficiency, Chronic | 2015 |
Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
Topics: Administration, Oral; Aged; Aminophylline; Caffeine; Cardiotonic Agents; Causality; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; New York; Purines; Pyrazoles; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents | 2017 |
Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging.
Topics: Administration, Intravenous; Aged; Aminophylline; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2017 |
Intravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aminophylline; Cardiotonic Agents; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Infusions, Intravenous; Male; Middle Aged; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Vasodilator Agents | 2018 |
8 other study(ies) available for aminophylline and regadenoson
| Article | Year |
|---|---|
Complete heart block associated with regadenoson: a real side effect.
Topics: Adenosine A2 Receptor Agonists; Aged; Aminophylline; Bronchodilator Agents; Female; Heart Block; Humans; Kidney Failure, Chronic; Kidney Transplantation; Myocardial Perfusion Imaging; Preoperative Period; Purines; Pyrazoles; Renal Dialysis; Treatment Outcome; Vasodilator Agents | 2012 |
Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Agonists; Aged; Aminophylline; Blood Pressure; Electrocardiography; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Retrospective Studies | 2013 |
Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla.
Topics: Adenosine A2 Receptor Agonists; Aged; Aminophylline; Blood Flow Velocity; Coronary Circulation; Coronary Sinus; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Regional Blood Flow | 2014 |
Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging.
Topics: Aminophylline; Caffeine; Exercise Test; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2017 |
Impact of Stress Cardiac Magnetic Resonance Imaging on Clinical Care.
Topics: Adenosine A2 Receptor Agonists; Aged; Aminophylline; Cardiotonic Agents; Clinical Decision-Making; Contrast Media; Coronary Artery Disease; Disease Management; Exercise Test; Female; Gadolinium; Heterocyclic Compounds; Humans; Logistic Models; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Organometallic Compounds; Patient Selection; Prospective Studies; Purines; Pyrazoles | 2016 |
Detrimental effects of nitroglycerin use during regadenoson vasodilator stress testing: A cautionary tale.
Topics: Aged; Aged, 80 and over; Aminophylline; Electrocardiography; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging; Nitroglycerin; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2018 |
Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Arrhythmias, Cardiac; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Eating; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Treatment Outcome | 2020 |
Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal.
Topics: Aminophylline; Drug-Related Side Effects and Adverse Reactions; Humans; Purines; Pyrazoles; Theophylline | 2023 |